285 related articles for article (PubMed ID: 29568754)
1. Monoamine Oxidase-A Inhibition and Associated Antioxidant Activity in Plant Extracts with Potential Antidepressant Actions.
Herraiz T; Guillén H
Biomed Res Int; 2018; 2018():4810394. PubMed ID: 29568754
[TBL] [Abstract][Full Text] [Related]
2. beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).
Herraiz T; González D; Ancín-Azpilicueta C; Arán VJ; Guillén H
Food Chem Toxicol; 2010 Mar; 48(3):839-45. PubMed ID: 20036304
[TBL] [Abstract][Full Text] [Related]
3. Identification, occurrence and activity of quinazoline alkaloids in Peganum harmala.
Herraiz T; Guillén H; Arán VJ; Salgado A
Food Chem Toxicol; 2017 May; 103():261-269. PubMed ID: 28279698
[TBL] [Abstract][Full Text] [Related]
4. Analysis of monoamine oxidase (MAO) enzymatic activity by high-performance liquid chromatography-diode array detection combined with an assay of oxidation with a peroxidase and its application to MAO inhibitors from foods and plants.
Herraiz T; Flores A; Fernández L
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():136-144. PubMed ID: 29268246
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MAO and COMT by hypericum extracts and hypericin.
Thiede HM; Walper A
J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S54-6. PubMed ID: 7857510
[TBL] [Abstract][Full Text] [Related]
6. Hyperforin as a possible antidepressant component of hypericum extracts.
Chatterjee SS; Bhattacharya SK; Wonnemann M; Singer A; Müller WE
Life Sci; 1998; 63(6):499-510. PubMed ID: 9718074
[TBL] [Abstract][Full Text] [Related]
7. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
[TBL] [Abstract][Full Text] [Related]
8. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
9. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.
Wurglics M; Schubert-Zsilavecz M
Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452
[TBL] [Abstract][Full Text] [Related]
10. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
[TBL] [Abstract][Full Text] [Related]
13. Biochemical activities of extracts from Hypericum perforatum L. 5th communication: dopamine-beta-hydroxylase-product quantification by HPLC and inhibition by hypericins and flavonoids.
Denke A; Schempp H; Weiser D; Elstner EF
Arzneimittelforschung; 2000 May; 50(5):415-9. PubMed ID: 10858868
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MAO by fractions and constituents of hypericum extract.
Bladt S; Wagner H
J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S57-9. PubMed ID: 7857511
[TBL] [Abstract][Full Text] [Related]
15. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L.
Sosa S; Pace R; Bornancin A; Morazzoni P; Riva A; Tubaro A; Della Loggia R
J Pharm Pharmacol; 2007 May; 59(5):703-9. PubMed ID: 17524236
[TBL] [Abstract][Full Text] [Related]
16. Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by beta-carboline alkaloids occurring in foods and plants.
Herraiz T; Chaparro C
J Chromatogr A; 2006 Jul; 1120(1-2):237-43. PubMed ID: 16386263
[TBL] [Abstract][Full Text] [Related]
17. Evidence for contributions of interactions of constituents to the anti-inflammatory activity of Hypericum perforatum.
Hammer KD; Birt DF
Crit Rev Food Sci Nutr; 2014; 54(6):781-9. PubMed ID: 24345048
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
Muruganandam AV; Bhattacharya SK; Ghosal S
Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
[TBL] [Abstract][Full Text] [Related]
19. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
[TBL] [Abstract][Full Text] [Related]
20. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors.
Herraiz T; Chaparro C
Biochem Biophys Res Commun; 2005 Jan; 326(2):378-86. PubMed ID: 15582589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
